Diligence memo · auto-generated · as of July 2, 2026
PSG of Orlando, LLC
PSG of Orlando, LLC looks under-valued against its niche peers and is dormant on financing cadence.
Businessfiled
PSG of Orlando, LLC operates in Pharmaceuticals, based in ST. PETERSBURG.
No verified homepage on file yet — operating evidence is limited to the public record.
Capital & rounds (filed)filed
PSG of Orlando, LLC has raised $138K in disclosed capital across 1 recorded round, aggregated from public filings. Its latest round is modeled as Pre-Seed (a round under $1.0M).
Largest single filing: $138K on 2013-08-23.
Most recent recorded round closed around 2013-08-23.
Valuation (modeled)modeled
Provath models PSG of Orlando, LLC at approximately $6.5M (range $77K–$74M). This is an algorithmic estimate from round sizes and same-niche peers — not a quoted or reported figure.
Read: Under-valued. Modeled value is 0.57× the median modeled value of Pre-Seed Pharmaceuticals companies in 2013–2015 (87 peers) — value vs value, same stage and era.
Financing rhythm & timingmixed
Last raise 12.9 yr ago; this sector typically re-raises about every 13 months.
Only one round on record and long silent — often defunct, acquired, or gone quiet.
Comparablesmixed
Capital scale ranks ahead of 2% of Pharmaceuticals peers (1613 compared).
Modeled value ranks above 11% of those peers.
Closest niche peers: IPM Safety Services, Inc., Scioderm, LLC, Chondrial Therapeutics, LLC, OnCore Biopharma, Inc., VR1 Corp.
Peoplefiled
6 named people on file across officers, directors and signatories.
Risks & flagsmixed
Financing has been silent well beyond sector cadence — possibly defunct, acquired, or paused.
No clearly named CEO/founder/principal in the surfaced records — key-person evidence is thin.